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Incidence, prevention, and management in spinal
cord protection during TEVAR
Adnan Z. Rizvi, MD, and Timothy M. Sullivan, MD, Minneapolis, MinnUntil recently, patients with aneurysms of the thoracic
and thoracoabdominal aorta had only one treatment op-
tion: open surgical repair. For those patients who could not
tolerate an operation because of medical comorbidities,
continued aneurysm enlargement and eventual rupture was
a constant, yet unpredictable threat to their lives. Several
studies have documented improved survival rates in those
patients treated surgically.1,2
Despite advances in surgical reconstruction and organ
protection, the mortality rate for elective surgical repair of
thoracoabdominal aortic aneurysm is 4% to 21%; advanced
age, renal failure, and postoperative paraplegia are the most
important risk factors predicting death at 30 days. In addi-
tion, for those patients aged 79 with an emergency pre-
sentation, history of diabetes or congestive heart failure,
30-day mortality is 50%. For aneurysms isolated to the
distal thoracic aorta, the risk of paraplegia is 0% to 4% and is
dependent on the extent of aorta replaced.3 A substantial
number of patients surviving the operation have prolonged,
complicated courses secondary to renal, cardiac, and pul-
monary dysfunction. Perhaps the most devastating compli-
cation of these complex procedures for patients and their
surgeon is paraplegia.4
A myriad of techniques have been developed to protect
the spinal cord during open surgical repair of the thoracic
and thoracoabdominal aorta, including clamp-and-sew,
distal aortic and visceral perfusion, complete cardiopulmo-
nary bypass, profound hypothermia and circulatory arrest,
direct spinal cord cooling, cerebrospinal fluid (CSF) drain-
age, and the use of pharmacologic adjuncts; some of these
principles may be useful in preventing paraplegia at the time
of endovascular repair. When the thoracic aorta is cross-
clamped, spinal arterial perfusion pressure decreases while
CSF pressure increases, resulting in decreased perfusion
pressure.
In an important study of 1004 patients by Safi et al,5
immediate postoperative neurologic deficit occurred in
6.8% of patients operated on without the adjuncts of CSF
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86Sdrainage and distal aortic perfusion, whereas only 2.4% of
those operated on with adjuncts suffered this devastating
complication. These authors also stressed the importance of
reimplantation of intercostal arteries, especially in the vul-
nerable area between T9 and T12, which frequently gives
rise to the anterior spinal artery. Relative hypertension in
the immediate postoperative period (maintaining mean
arterial pressure between 90 and 100 mm Hg) is also
advocated. Other risk factors for paraplegia in their series
included extent of aneurysmal disease, advanced age, emer-
gency presentation, preoperative renal dysfunction, active
smoking, and cerebrovascular disease. Delayed paraplegia
has been noted as late as 2 weeks after surgery, and has been
successfully treated by placement of a spinal drain.6
PARAPLEGIA AND PARAPARESIS IN THE ERA
OF THORACIC ENDOVASCULAR AUERYSM
REPAIR
Substantial controversy exists with respect to elective
repair of abdominal aortic aneurysms with endografts in
good-risk patients due to the excellent perioperative mor-
tality and long-term durability of open surgical repair.7 The
promise of endovascular repair of thoracic aortic aneurysms
(TEVAR), however, is one of decreased perioperative mor-
tality and morbidity, especially with respect to paraplegia,
permanent renal failure and stroke, in a population of
patients who heretofore did not have an alternative to open
surgical therapy or expectant treatment. Although there is a
paucity of well-controlled data on which to base definitive
statements and clinical practice, a review of case series
within the available literature allows for some general as-
sumptions to be made.
In one of the first reported series byDake et al8 in 1994,
13 patients were treated with homemade endovascular
stent grafts during a 24-month period. All grafts were
successfully deployed, no patients died, and no patients
suffered stroke, paraplegia, or distal embolization; these
results generated incredible enthusiasm for this novel pro-
cedure.
Subsequent reports in larger groups of patients were
more sobering, however. The European Collaborators on
Stent-Graft Techniques for Aortic Aneurysm Repair
(EUROSTAR) andUnited Kingdom registries, reported in
2004 by Leurs et al,9 examined 443 patients who had
undergone endovascular repair of a variety of pathologies
involving the thoracic aorta, including degenerative aneu-
rysms, aortic dissections, anastomotic aneurysms, and trau-
matic ruptures. In the entire cohort, 11 instances of para-
plegia or paresis occurred, for an incidence of 2.5%. Ten of
mortality calculation.
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group that had an atherosclerotic aneurysm. One patient in
the aortic dissection group and no patients in the false
aneurysm or traumatic rupture groups were affected. Given
the heterogeneous nature of the patient population and
practice variability across the 62 participating centers, there
are no reported data regarding the use of spinal drains.
Chiesa et al10 reported 103 patients treated electively
for thoracic aortic lesions, 88 (85%) of which were athero-
sclerotic aneurysms. Preoperative CSF drainage was used in
seven patients (based on data extrapolated from their expe-
rience with open surgical repair), including those with
aneurysms involving critical intercostal arteries at T8 to
T12, those requiring coverage of a long segment of the
thoracic aorta (20 cm), and in patients with prior repair of
an abdominal aortic aneurysm. Four patients (4%) had
delayed neurologic deficit that completely resolved after
the institution of CSF drainage, systemic steroid therapy,
and pharmacologic support of blood pressure. Univariate
analysis identified only a perioperative mean arterial blood
pressure of 70 mm Hg as a significant predictor of spinal
cord ischemia (P  .0001).
Greenberg et al11 prospectively evaluated their results
in 100 patients treated with investigational Zenith devices
(Cook, Bloomington, Ind) at Cleveland Clinic. Of note, a
spinal drain was placed in 84% of their patients preopera-
tively. Acute spinal cord ischemia (SCI) was noted in 7.4%
of 81 patients treated for atherosclerotic aneurysms, al-
though only two of these six patients had a permanent
deficit. No paraplegia or paraparesis developed in patients
with aneurysm or other indications who were treated for
chronic dissection.
Finally, Makaroun et al12 reported results from a mul-
ticenter trial of the Gore TAG thoracic endograft (W. L.
Gore and Associates, Flagstaff, Ariz) in which 139 patients
underwent successful implantation of the device. Spinal
drains were not routinely placed before the procedures.
Temporary or permanent spinal cord deficit developed in
four patients (3%). Paraplegia was found in one patient
immediately after the procedure that did not resolve after
placement of a spinal drain. In a second patient, symptoms
developed 6 hours after surgery associated with an episode
of hypotension. Symptoms improved—but did not abate
entirely—after stabilization of blood pressure and place-
ment of a spinal drain. Symptoms in the third and fourth
patients developed on the first postoperative day, and both
were ambulating at the time of their discharge.
Mortality and the incidence of paraplegia/paraparesis
after thoracic aortic endografting, compiled from the peer
reviewed literature (and reporting at least 20 cases) are
listed in Table I. The weighted average mortality at 30 days
was 6.6% in this complex patient group (range, 0% to 19%).
Similarly, there was a broad range in the incidence of SCI,
with an average of 3.9% in 5349 patients (range, 0% to
13.3%).
A review of these citations suggests that there is no
consensus regarding the use of CSF drains in patients
undergoing TEVAR; some centers use spinal drains selec-Table I. Mortality and incidence of
paraplegia/paraparesis after endovascular repair of
thoracic aortic pathology (1999-2009)
Author, year No.
30-day
mortality
Paraplegia/
paraparesis
No. (%) No. (%)
Mitchell, 1999 103 9 (9) 3 (3)
Won, 2001 23 0 0
Taylor, 2001 37 3 (8) 0
White, 2001 26 1 (4) 1 (4)
Gravereaux, 2001 53 0 3 (5.6)
Cambria, 2002 28 1 (3.5) 0
Thompson, 2002 46 2 (4.3) 0
Criado, 2002 47 1 (2.1)a 0
Lepore, 2002 43 3 (7) 3 (6.9)
Usui, 2002 24 0 3 (12.5)
Ellozy, 2003 84 5 (6) 3 (3.6)
Bell, 2003 67 5 (7.4) 3 (4.5)
Chabbert, 2003 47 4 (8.5) 0
Krohg-Sorensen, 2003 20 2 (10) 0
Lambrechts, 2003 26 0 0
Schoder, 2003 28 0 0
Matravers, 2003 24 2 (7) 0
Lamme, 2003 21 0 0
Orend, 2003 74 7 (9.5) 2 (2.7)
Neuhauser, 2004 31 6 (19) 2 (6)
Bortone, 2004 132 4 (4) 0
Brandt, 2004 22 1 (4.5) 1 (4.5)
Leurs, 2004 443 41 (9) 11 (2.5)
Hansen, 2004 59 10 (16.9) 1 (1.7)
Makaroun, 2005 139 2 (1.5) 4 (3)
Chiesa, 2005 103 1 (1) 4 (4)
Greenberg, 2005 100 17 (17) 6 (6)
Melissano, 2005 45 0 1 (2)
Chiesa, 2005 103 2 (2) 4 (4)
Iyer, 2006 70 1 (2.9) 0 (0)
Morales, 2007 186 15 (8) 7 (3.7)
Buth, 2007 606 60 (9.9) 15 (2.5)
Khoynezhad, 2007 153 15 (9.8) 8 (5.2)
Kawaharada, 2007 149 3 (2) 3 (2)
Sandroussi, 2007 65 3 (4.6) 2 (3)
Qu, 2008 87 8 (9.2) 3 (3)
Amabile, 2008 67 6 (8.9) 5 (7.5)
Feezor, 2008 326 24 (7.4) 33 (10)
Misfeld, 2008 56 3 (5.4) 2 (3.6)
Pearce, 2008 127 17 (13.3) 17 (13.3)
Hnath, 2008 121 Not reported 5 (4.1)
Siegenthaler, 2008 21 1 (4.8) 1 (4.8)
Matsumura, 2008 160 3 (1.9) 9 (5.6)
Fairman, 2008 195 4 (2.1) 17 (8.7)
Kim, 2009 72 0 (0) 0 (0)
Preventza, 2009 346 Not reported 14 (4)
Nakamura, 2009 36 0 (0) 1 (2.8)
Kische, 2009 180 9 (5) 5 (2.8)
Nienaber, 2009 72 2 (2.9) 2 (2.9)
Chaikof, 2009 197 12 (6) 4 (2)
Cambria, 2009 59b 7 (11.9) 1 (1.7)
Total 5349 322 (6.6)c 209 (3.9)
aAn additional patient died of aortic rupture after 30 days.
bAll 59 patients presented with acute aortic pathology.
cTwo studies with mortality not recorded were not included in overall
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them only after patients become symptomatic in the post-
operative period. The use of this important adjunct must be
individualized and must also be based on its safety and ease
of use in the individual institution. Placement of a spinal
drain is not entirely benign, but with well-trained person-
nel, placement and management of a spinal drain can be
performed with minimal morbidity and mortality.
In a recent review by Estera et al13 spanning 15 years
and 1107 patients, CSF drain placement for open thoraco-
abdominal surgery showed a technical success rate of 99.8%
and a drain-related complication rate of 1.5%. Subdural
hematoma developed in five patients (0.4%); however,
since implementing a limited CSF drainage protocol, this
complication has not developed in any patients.
Certain clinical situations may prevent the placement of
a spinal drain, such as patients with symptomatic or rup-
tured thoracic aortic pathology or patients with prior lum-
bar spine surgery. Indications for placing a spinal drain,
based on our current practice, are listed in Table II. The
drain remains in place for 24 hours in an intensive care unit
setting, and is then removed. While in place, it is allowed to
drain to maintain a CSF pressure of 10 mm Hg. Table III
outlines our institution’s protocol for managing CSF drains
after TEVAR.
RISK FACTORS FOR DEVELOPING SCI AFTER
TEVAR
Numerous groups have tried to identify patient or
procedural variables that may increase the risk of SCI
during TEVAR. Preventza et al14 reviewed 346 consecu-
tive TEVAR procedures spanning 8 years. TEVAR was
performed for atherosclerotic aneurysms in 45.9%, acute
and chronic dissections in 31.5%, penetrating ulcers in
8.9%, and miscellaneous lesions in 13.6%. Fourteen pa-
tients (4%) developed paraparesis (1.7%) or paraplegia
(2.3%). CSF drainage was used in seven of eight paraplegic
patients. Paraplegia after TEVAR was associated with fe-
male gender, long segment coverage, and aneurysmal dis-
ease of the thoracic aorta.
Khoynezhad et al15 reviewed 153 patients who under-
went TEVAR for various pathologies. This cohort had an
overall paraplegia rate of 5.2% (8 patients), with permanent
Table II. Indications for the use of cerebrospinal drains
in patients requiring thoracic endografts
1. Anticipated endograft coverage of T9 to T12 (location of
anterior spinal artery)
2. Coverage of a long segment of thoracic aorta (20 cm)
3. Compromised collateral pathways; for example, previous
infrarenal aortic aneurysm repair, occluded hypogastric
arteries, coverage of the left subclavian artery without
revascularization
4. Symptomatic spinal ischemia in a patient who did not have a
drain placed preoperatively
5. Extensive aneurysmal diseasedeficit in four patients. On univariate analysis, aneurysmalpathology, use of an iliac conduit, and coverage of a hypo-
gastric artery were highly associated with a spinal cord
injury after TEVAR.
From the EUROSTAR registry, Buth et al16 found an
overall paraplegia or paraparesis rate of 2.5% in 606 patients
treated with TEVAR for various thoracic aortic patholo-
gies. Their multivariate regression analysis showed four
factors were associated with a higher incidence of SCI: left
subclavian artery coverage without revascularization, renal
failure, concomitant open abdominal aortic surgery, and
Table III. Minneapolis Heart Institute at Abbott
Northwestern Hospital: Spinal cord pressure monitoring
and cerebrospinal fluid drainage protocol after thoracic
aortic procedures
Vital signs and monitoring parameters
● Every hour for 8 hours then Q 2 hours
● If the head of bed (HOB) is 15 degrees assess neurologic
status prior to elevating the HOB and Q 15 minutes while the
HOB is elevated
● Spinal cord assessment should include hip flexion, feet dorsi/
plantarflexion
● Spinal cord pressure (SCP) monitoring
X Monitor SCP and spinal cord perfusion pressure Q hourly
X Maintain SCP 10 mm Hg. If SCP elevated, place HOB
flat and ensure drain is patent
X Maintain spinal cord perfusion pressure 60 mm Hg and
mean arterial pressure (MAP) 80 mm Hg
X Use Neo-Synephrine IV infusion as necessary
Activity
● HOB 1 to 15 degrees, OK to raise HOB for meals
● Do not change HOB position without consultation with vas-
cular surgery
Nursing
● No anticoagulation while drain is in place
● Continuous CSF draining
X If CSF output 20 mL/h  2 hours or 150 mL over 8
hours, clamp drain and notify neurointerventional radiology
X If patient is intubated, clamp drain during positioning or
suctioning
● Notify vascular surgery
X Changes in neurological function
X Patient complains of a headache, clamp the drain and notify
surgeon
X CSF output 20 mL/h  2 hours or 150 mL over 8
hours, clamp drain and notify surgeon
X SCP 10 mm HG or SCPP 60 mm Hg for more than 10
minutes
X MAP 80 mm Hg
X CSF leak at insertion site
X New blood in the lines
X New signs of meningeal irritation
X Temperature 38.5° C
X INR 1.5
X Hemoglobin 10 mg/dL
X Platelet count 100,000
● Pneumatic compression device
Prophylaxis antibiotics until the drain is out
● Ancef or vancomycin IV
Laboratory
● INR 4 hours after drain placement and daily until drain is out
● Hgb and platelet count 4 hours after drain placement and
dailyuse of three or more stent grafts to treat the lesion.
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in 326 patients to determine if the extent of coverage of the
aorta was a significant risk factor. SCI developed in 33
patients (10%), and these patients tended to be older
(72.7  10.6 vs 64.7  15.8 years) and had longer intra-
operative procedure times. An analyses of the amount of
aorta covered found that patients who developed SCI had a
greater absolute length (260 40.9 vs 185.8 81.6 mm)
as well as proportionate length (88.8% 12.1% vs 67.6%
24%) of thoracic aorta covered compared with patients
without an SCI after TEVAR. Conversely, the mean length
of uncovered aorta proximal to the celiac artery was much
less in patients who developed SCI compared with those
that did not (17.3  21.8 vs 63.1  62.9 mm). A similar
finding was seen in a study by Amabile et al18 examining 67
patients who underwent TEVAR from 2000 to 2005. SCI
developed in five (7.5%) patients after TEVAR. Multivari-
ate logistic regression analysis showed that 205 mm of
aortic coverage with a stent graft was the only significant
predictor for SCI.
In a recent systematic review and meta-analysis by
Cheng et al19 comparing TEVAR with open surgery for
descending thoracic aortic disease, 42 studies with 5888
patients were reviewed. The overall incidence of SCI was
3.4% in the TEVAR group and 8.2% in the open surgery
group, which was highly statistically significant. Interest-
ingly, the odds ratio for paraplegia did not differ by the type
of study (prospective vs retrospective design, historic vs
concurrent control, or consecutive vs nonconsecutive pa-
tient recruitment). In addition, their meta-regression anal-
ysis did not show any difference in the incidence of SCI by
year of study or year of patient recruitment, suggesting that
the overall incidence of SCI after TEVAR has not changed
significantly with time.
The relationship between coverage of the left subcla-
vian artery and spinal cord injury appears to be significant.
In a recent systematic review and meta-analysis by Rizvi et
al20 of 51 manuscripts, only 8 described left subclavian
artery coverage and SCI (See the article by Drs Matsumura
andRizvi, Fig 3).Thismeta-analysis foundSCIhaddeveloped
in 27 of 673 patients (4%). The authors documented that left
subclavian artery coverage without revascularization during
TEVAR resulted in a nonsignificant increase in risk of SCI
compared with those who underwent left subclavian artery
revascularization before TEVAR. Analyzing the 15 patients
who developed paraplegia/paraparesis in the EUROSTAR
Registry, they found that the incidence of left subclavian artery
coverage without revascularization was 40% in the patients
who developed SCI comparedwith 19% in those patients who
did not develop SCI, which was significantly higher (odds
ratio, 2.82; 95% confidence interval, 1.00-8.08).16
STRATEGIES TO REDUCE SCI AFTER TEVAR
Adjuncts to reduce the incidence of SCI after open
thoracoabdominal aortic surgery have been well described.
A similar approach has been used in patients undergoing
TEVAR who are at high risk for SCI. Cheung et al21reviewed their experience with selective lumbar CSF drain-age and somatosensory evoked-potential monitoring in a
subset of patients they determined were at high risk (prior
AAA repair or significant aneurysm extent) for SCI after
TEVAR. Paraplegia or paraparesis occurred in 5 of 75
patients (6.6%). Two patients had detectable somatosen-
sory evoked-potential loss after stent deployment. Four of
the five with this complication had complete recovery, and
one had nearly complete recovery, after blood pressure
augmentation or CSF drainage, or both. They concluded
that early detection and aggressive intervention to increase
the spinal cord perfusion pressure are effective in decreasing
the magnitude of SCI after TEVAR in patients at high risk
for paraplegia.
Weigang et al22 came to a similar conclusion in their
study of 31 patients undergoing TEVAR, all of whom had
preoperative CSF drainage, somatosensory-evoked poten-
tial monitoring, and avoidance of hypotension. During the
procedure, 11 of 31 patients (35%) demonstrated changes
in evoked-potentials that were managed with CSF drainage
and blood pressure augmentation. Paraparesis developed in
one patient (3.2%) at 25 days after TEVAR.
In an important study from the Albany group,Hnath et
al23 examined their institution’s results regarding the use of
CSF drainage in 121 patients who underwent TEVAR.
They instituted a protocol of routine placement of a CSF
drain and augmentation of the blood pressure to maintain a
mean arterial blood pressure 90 mm Hg in 56 patients
compared with 65 patients who did not have routine CSF
drainage or blood pressure augmentation. The incidence of
SCI after the protocol was initiated was 0% in the group
with routine CSF drainage vs 8% in the group without
routine CSF drainage (P .05). Although their data would
suggest that mandatory CSF drainage in all patients under-
going TEVAR could substantially reduce the incidence of
SCI, further subset analysis determined that patients at risk
for SCI who did not undergo CSF drainage included prior
AAA repair and those with extensive thoracic aortic cover-
age and coverage of the left subclavian artery without
revascularization.
Coverage of the important intercostal arteries between
T9 and T12 during TEVAR is inevitable in patients with
extensive disease of the thoracic aorta. A novel stent graft
design has been described by Shimamoto et al24 based on a
fenestrated Inoue thoracic stent graft. In a canine model,
they described five successful deployments of a thoracic
stent graft with a fenestrated side-branch consisting of a
small caliber Dacron graft and a 3-mm diameter bare-metal
coronary stent into the T 11 intercostal artery. At 12
months after angiography, all fenestrated stents remained
patent with a mean in-stent stenosis of 33%.
CONCLUSIONS
The mechanisms of SCI and stroke after endovascular
repair or thoracic aortic pathologies are likely multifactorial
and remain poorly defined. A thorough knowledge of the
etiology of these complications after open surgical repair of
thoracic and thoracoabdominal aortic aneurysms is essen-
tial as we attempt to eliminate them after TEVAR. Partic-
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increased risk for SCI—underlying aortic pathology being
treated, extent of aorta to be covered with an endograft,
compromise of collateral pathways to the anterior spinal
artery (ie, planned coverage of the left subclavian artery or
diseased hypogastric arteries), and prior infrarenal aortic
surgery—may allow for modifications in technique to de-
crease their incidence. Adjuncts to decrease the risk of SCI,
such as CSF drainage, augmentation of blood pressure, and
use of somatosensory evoked-potentials, are useful in pa-
tients deemed at high risk for developing SCI.
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